While IPOs allow companies to tap into capital markets, going public provides liquidity to early-stage investors seeking to unload stock positions.
News & Analysis: Aprea Therapeutics Inc
The drug candidate is in phase 3 trials as a treatment of myelodysplastic syndrome (MDS), which often leads to blood and bone marrow cancers.
Incredibly, they're almost all health stocks, including 7 biotechs, an eye surgery platform, and a medical device company.
Three biotech companies successfully completed IPOs last week. Would investors have been better off buying shares on the open market?